"At The Harry and Jeanette Weinberg Cancer Institute, our patients receive superior cancer care, access to clinical trials, and the latest diagnostic tests and treatments, along with the support that comes from a welcoming community environment. Accredited since 1995 by the American College of Surgeons' Commission on Cancer as a teaching hospital cancer program, we offer coordinated and comprehensive care to not only cancer patients, but to their families as well."

During the past decade, MedStar Franklin Square Medical Center/Weinberg Cancer Institute conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 67 clinical trials were completed, i.e. on average, 119.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 36 clinical trials were completed. i.e. 211.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 13 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" are "Breast Cancer" (15 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Colorectal Cancer" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials) and "Ovarian Transitional Cell Carcinoma" (8 trials). Many other conditions were trialed in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" in a lesser frequency.

Most popular intervention types in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" are "Drug" (107 trials), "Other" (79 trials), "Biological" (48 trials), "Procedure" (24 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (32 trials), "Carboplatin" (24 trials), "Paclitaxel" (24 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute" are 84 trials for "All" genders and 54 trials for "Female" genders.

Currently, there are NaN active trials in "MedStar Franklin Square Medical Center/Weinberg Cancer Institute". undefined are not yet recruiting, 17 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in MedStar Franklin Square Medical Center/Weinberg Cancer Institute, 2 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in MedStar Franklin Square Medical Center/Weinberg Cancer Institute, 2 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".